IRCT20220117053747N2
Recruiting
Phase 2
Comparison of therapeutic, immunity and efficacy of topical hydrogen peroxide solution (40% vol) with cryotherapy in seborheic keratosis.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tabriz University of Medical Sciences
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age over 18 years
- •Patient with definite diagnosis of seborrheic keratosis according to diagnostic criteria (Existence of at least one separate lesion in the trunk or limbs with a depth of 0 to 2 mm and length and width of 5 to 15 mm)
- •Existence of at least 4 lesions of seborrheic keratosis in the individual
- •Satisfaction to participate in the study
Exclusion Criteria
- •Presence of the lesion at the site of hair growth (so that the medicine does not reach the lesion well)
- •Presence of a lesion on the eyelid
- •Lesions at a distance of 5 mm from the eye
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Pre-viously Untreated Extensive-Stage Small-Cell Lung Cancer: A Systematic Review and Network Me-ta-analysisExtensive stage small cell lung cancerJPRN-UMIN000041702Showa University3,879
Recruiting
Phase 2
Investigating the effect of Byolic CC product consumption along with standard treatment in patients with colon cancercolon cancer.Malignant neoplasm of colonIRCT20240304061158N3Behpad Teb Iranian70
Completed
Phase 3
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
Active, not recruiting
Phase 1
Clinical efficacy, immunogenicity, clinical tolerability and assessment of safety of gpASIT+TM administered orally, according to two administration schedules, for the prophylaxis of seasonal grass pollen rhinoconjunctivitis - Not availableTreatment of seasonal grass pollen rhinoconjunctivitisMedDRA version: 12.1Level: LLTClassification code 10019170Term: Hay feverEUCTR2010-023176-12-BEBiotech Tools sa414
Not yet recruiting
Not Applicable
A clinical trial to study effects of oral and long acting injectable antipsychotic in patients with schizophrenia.Health Condition 1: F20- SchizophreniaCTRI/2020/02/023446Government Medical College and Hospital Chandigarh Sector